Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Nordic
 
Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden
Authors: Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong
Affiliations: IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden
Publications: 
ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Denmark, Finland, Nordic, Norway, Sweden
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34089-6/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301519340896%3Fshowall%3Dtrue#%20
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment 2019 English , Review
 
 
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES
Authors: Svanström, Henrik [ 1 ]; Trojcakova, Iveta [ 1 ]; Pitcher, Ashley [ 1 ]
Affiliations: IQVIA, Copenhagen, Denmark
Publications: 
Document Types: , Abstract
Countries: , Nordic
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub
Condition Year Language Analysis type
, Public Health 2019 English , Database Study, Epidemiological study, Longitudinal study, Observational study, Survey research
 
 
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES
Authors: H.SvanströmI.TrojčákováA.Pitcher
Affiliations: IQVIA, Copenhagen, Denmark
Publications: 
Journal: VALUE IN HEALTH Volume: 22 Pages: S768-S768 Supplement: 3
Document Types: , Abstract
Countries: , Nordic
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub
Condition Year Language Analysis type
, Public Health 2019 English , Population Based Study
 
 
Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden
Authors: Lindmark K, Boman K, Olofsson M, Törnblom M, Levine A, Castelo-Branco A, Schlienger R, Wirta SB, Stålhammar J, Wikström G
Affiliations: Real-World & Analytics Solutions, IQVIA, Solna, Sweden
Publications: 
Clinical Epidemiology
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.dovepress.com/articles.php?article_id=44704
Condition Year Language Analysis type
, Cardiovascular disease 2019 English , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis
 
 
Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden.
Authors: Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T
Affiliations: Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde)
Publications: 
Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041
Condition Year Language Analysis type
, Oncology 2019 English , Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis
 
 
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden
Authors: "Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group"
Affiliations: *Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland
Publications: 
AAN, Philadelphia, USA, 4-10 May 2019
Document Types: , Oral presentation
Countries: , Europe, Finland, Nordic, Sweden
Abstract: https://n.neurology.org/content/92/15_Supplement/S49.005
Condition Year Language Analysis type
, Neurological disorders 2019 English , Epidemiological study, Population Based Study
 
 
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS
Authors: Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group
Affiliations: 1StatFinn-EPID Research, Espoo, Finland
Publications: 
ECTRIMS, Stockholm, Sweden, 11-13 September, 2019
Document Types: , Poster
Countries: , Finland, Nordic, Sweden
Abstract: https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/278346/pasi.korhonen.prevalence.of.infant.outcomes.at.birth.after.exposure.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmontgomery
Condition Year Language Analysis type
, Neurological disorders 2019 English , Epidemiological study, Population Based Study, Retrospective cohort analysis
 
 
CLUE: Consequences for life of children with in utero exposure to metformin in Finland
Authors: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Affiliations: Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Publications: 
The International Diabetes Federation (IDF) Congress 2019
Document Types: , Oral presentation
Countries: , Finland, Nordic
Condition Year Language Analysis type
, Diabetes 2019 English , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis
 
 
Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study
Authors: Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.
Affiliations: EPID Research Oy, Espoo, Finland
Publications: 
BMJ
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402043/
Condition Year Language Analysis type
, Mental health 2019 English , Epidemiological study, Retrospective database analysis
 
 
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Authors: Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM
Affiliations: VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag.
Publications: 
Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273.
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368
Condition Year Language Analysis type
, Oncology 2019 English , Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis
 
 
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Authors: Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations: 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publications: 
Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Types: , Article
Countries: , Canada, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937
Condition Year Language Analysis type
, Obesity 2019 English
 
 
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
Authors: Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C
Affiliations: Work Environment Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Publications: 
Respiratory Research (2018) 19:12
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0719-x
Condition Year Language Analysis type
, Respiratory disease 2018 English , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study
 
 
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)
Authors: Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K
Affiliations: Respiratory, Allergy and Sleep Research, Dept of Medical Sciences, Uppsala University, Uppsala, Sweden
Publications: 
European Respiratory Journal (2018) 52: 1701927
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://erj.ersjournals.com/content/52/2/1701927
Condition Year Language Analysis type
, Respiratory disease 2018 English , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study
 
 
Total cost of health care resource utilization for asthma patients in Sweden with different exposures to oral corticosteroids
Authors: Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Christensen H, Larsson K
Affiliations: Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Sweden
Publications: 
Allergy. European Journal of Allergy and Clinical Immunology, Vol. 73, no Suppl.105, p. 529-529
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://uu.diva-portal.org/smash/record.jsf?pid=diva2%3A1260079&dswid=-316
Condition Year Language Analysis type
, Respiratory disease 2018 English , Clinical setting: Primary care, Cost analysis
 
 
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Authors: Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW
Affiliations: StatFinn & EPID Research, Espoo, Finland
Publications: 
Endocrinol Diabetes Metab.
Document Types: , Article
Countries: , Denmark, Finland, Nordic, Norway, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
Condition Year Language Analysis type
, Diabetes 2018 English , Population Based Study, Retrospective database analysis
 
 
#4018 Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study
Authors: Simon Ekman,Maria Planck, Jens Benn Sørensen, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez-Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun
Affiliations: Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium, Department of Oncology, Radiumhospitalet, Oslo, Norway
Publications: 
Document Types: , Poster
Countries: , Nordic, UK
Condition Year Language Analysis type
2018 English , Retrospective cohort analysis
 
 
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.
Authors: Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2.
Affiliations: Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden.
Publications: 
Document Types: , Article
Countries: , Nordic, UK
Condition Year Language Analysis type
, Hematology, Rare disease 2018 English , Retrospective database analysis
 
 
Can patients accurately report their drugs? -A comparison of self-reported medication with a national register in Denmark in a subset of the protect pregnancy cohort.
Authors: Bourke A, Laursen M, Dreyer N, Hallgreen CE, Blackburn S
Affiliations: 
Publications: 
Pharmacoepidemiol Drug Saf 2018; 27 (2):87
Document Types: , Poster
Countries: , Nordic
Condition Year Language Analysis type
, Pregnancy, Womens Health 2018 English
 
 
#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study
Authors: Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck
Affiliations: Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden
Publications: 
Document Types: , Poster
Countries: , England, Nordic, UK
Condition Year Language Analysis type
, Oncology 2018 English , Retrospective cohort analysis
 
 
Predictors and diseasburden of ulcerative colitis progression in Sweden.
Authors: Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4
Affiliations: 1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA.
Publications: 
UEG Barcelona September 2017
Document Types: , Abstract
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Immunology and Vaccination 2017 English , Retrospective cohort analysis
 
 
Description of a national pulmonary fibrosis cohort in Sweden.
Authors: Bartley K1, A Levine A2, Arnheim-Dahlstrom L2, Ferrara G3,4, Kirchgaessler K5, Linder R2, Janson C6, Sköld CM3
Affiliations: 1 Genentech, Inc., South San Francisco, CA, USA 2 IMS Health, Solna, Sweden 3 Karolinska University Hospital, Stockholm, Sweden 4 Karolinska Institutet, Stockholm, Sweden 5 Hoffmann-La Roche, Ltd., Basel, Switzerland 6Uppsala University, Uppsala, Sweden
Publications: 
British Thoracic Society Winter Meeting 2017, London
Document Types: , Abstract
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Respiratory disease 2017 English , Retrospective cohort analysis
 
 
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis.
Authors: Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7
Affiliations: 1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden
Publications: 
ISPOR 20th Annual European Congress
Document Types: 
Countries: , Germany, Nordic, Sweden
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY
Condition Year Language Analysis type
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology 2017 English , Retrospective database analysis
 
 
Prevalence, characteristics and management of asthma patients with frequent exacerbations ? an observational study in Sweden (PACEHR).
Authors: Janson C1, Lisspers K2, Ställberg B2, Johansson G3, Thuresson M4, Telg G4, Larsson K5.
Affiliations: 1 Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 2 Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 4 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 5 Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm
Publications: 
Document Types: , Abstract
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Respiratory disease 2017 English
 
 
Healthcare resource utilization associated with heart failure with preserved versus reduced ejection fraction: a retrospective population-based cohort study in Sweden
Authors: Boman K, Lindmark K, Olofsson M, Stalhammar J, Bergman GJ, Tornblom M, Bruce Wirta S, Costa-Scharplatz M, Calado F, Wikstrom G
Affiliations: Umea University, Research Unit, Medicine, Skellefteå, Department of Public Health and Clinical Medicine, Umea, Sweden|QuintilesIMS, Solna, Sweden
Publications: 
European Journal of Heart Failure (2017); 19 (Suppl. S1): 5–601
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.833
Condition Year Language Analysis type
, Cardiovascular disease 2017 English , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study, Retrospective database analysis
 
 
Management of Patients with Heart Failure with Preserved Versus Reduced Ejection Fraction: A Retrospective Population-Based Cohort Study in Sweden
Authors: Stålhammar J, Boman K, Olofsson M, Wikström G, Jonasdottir Bergman G, Törnblom M, Wintzell V, Bruce Wirta S, Proenca CC, Schlienger R, Lindmark K
Affiliations: Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden
Publications: 
European Journal of Heart Failure ( 2017 );19(Suppl. S1):54
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: https://esc365.escardio.org/Congress/Heart-Failure-2017-4th-World-Congress-on-Acute-Heart-Failure/Poster-Session-1-Chronic-heart-failure/152428-management-of-patients-with-heart-failure-with-preserved-versus-reduced-ejection-fraction-a-retrospective-population-based-cohort-study-in-sweden
Condition Year Language Analysis type
, Cardiovascular disease 2017 English , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study, Retrospective database analysis
 
 
Drug Treatment Patterns in Patients Newly Diagnosed with Heart Failure: A Retrospective Population-Based Cohort Study in Sweden
Authors: Wikström G, Lindmark K, Olofsson M, Stålhammar J, Jonasdottir Bergman G, Johansson S, Wintzell V., Bruce Wirta S, Balas B, Boman K
Affiliations: Uppsala University, Institute for Medical Sciences - Uppsala - Sweden||IMS Health Sweden, Stockholm, Sweden
Publications: 
European Journal of Heart Failure ( 2017 ) 19 ( Suppl. S1 ), 55
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: https://esc365.escardio.org/Congress/Heart-Failure-2017-4th-World-Congress-on-Acute-Heart-Failure/Poster-Session-1-Chronic-heart-failure/152433-drug-treatment-patterns-in-patients-newly-diagnosed-with-heart-failure-a-retrospective-population-based-cohort-study-in-sweden
Condition Year Language Analysis type
, Cardiovascular disease 2017 English , Population Based Study, Retrospective cohort analysis
 
 
Characteristics of asthma patients with frequent exacerbations ? an observational study in Sweden
Authors: Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K
Affiliations: Uppsala University, Uppsala, Sweden
Publications: 
European Journal of Respiratory Research (2017) 50: PA3870
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://erj.ersjournals.com/content/50/suppl_61/PA3870
Condition Year Language Analysis type
, Respiratory disease 2017 English , Population Based Study, Retrospective cohort analysis
 
 
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study
Authors: Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M
Affiliations: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Publications: 
European Neuropsychopharmacology(2017);27(4): S855–S856
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: https://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)31536-5/fulltext
Condition Year Language Analysis type
, Mental health 2017 English , Population Based Study, Retrospective database analysis
 
 
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation
Authors: Jensen ML1,2, Jørgensen ME1, Hansen EH2, Aagaard L3, Carstensen B1.
Affiliations: 1 Steno Diabetes Center Copenhagen, Gentofte, Denmark. QuintilesIMS 2 Faculty of Health and Medical Sciences, Department of Pharmacy, Section for Social and Clinical Pharmacy, Universitetsparken 2, University of Copenhagen,Denmark. 3 Faculty of Health, University of Southern Denmark, Odense, Denmark.
Publications: 
PLoS One. 2017; 12(6): e0179546.
Document Types: , Article
Countries: , Denmark, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493299/
Condition Year Language Analysis type
, Clinical practice, Diabetes 2017 English , clinical setting: Secondary care, Compliance, Epidemiological study, Retrospective cohort analysis
 
 
Antibiotic prescribing during infancy and risk of treated airway diseases among children born in Denmark 2004-2012.
Authors: Kinlaw A, Sørensen HT, Lund JL, Mack CD, Lars P, Daniels JL, Kappelman MD, Stürmer T.
Affiliations: Triangle Comparative Effectiveness Research Symposium
Publications: 
Document Types: , Presentation
Countries: , Nordic
Condition Year Language Analysis type
, Pregnancy 2017 English
 
 
Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden
Authors: Lind M1,2, Matsson PO3, Linder R4, Svenningsson I5, Jørgensen L6, Ploug UJ7, Gydesen H7, Dorkhan M8, Larsen S8, Johansson G9.
Affiliations: 1Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden. lind.marcus@telia.com. 2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com. 3Domnarvet VC, Borlänge, Sweden. 4Pygargus, Stockholm, Sweden. 5Research and Development Unit, Primary Health Care, Närhälsan, Vänersborg, Sweden. 6IMS Health, Stockholm, Sweden. 7Novo Nordisk A/S, Søborg, Denmark. 8Novo Nordisk Scandinavia AB, Malmö, Sweden. 9Department of Caring Sciences and Family Medicine, Uppsala University, Uppsala, Sweden.
Publications: 
Diabetes Ther
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900983/
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective cohort analysis
 
 
Population-based study of giant cell tumor of bone in Sweden (1983-2011).
Authors: Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5
Affiliations: 1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com. 2Pygargus/IMS Health, Stockholm, Sweden. 3Amgen Inc. Thousand Oaks, CA, USA. 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden. 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden.
Publications: 
Cancer Epidemiol
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(16)30039-X/abstract
Condition Year Language Analysis type
, Oncology 2016 English , Real World Evidence
 
 
Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.
Authors: Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1,3, Johansson G4, Levin LÅ5, Sobocki P3,6, Gandra SR7.
Affiliations: 1Quantify Research, Stockholm, Sweden. 2Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 3LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 5Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 6IMS Health, Stockholm, Sweden. 7Amgen Inc., Thousand Oaks, CA, United States.
Publications: 
Int J Clin Pract
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819716/
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Epidemiological study
 
 
Exposure to heart failure treatments in newly diagnosed patients in Sweden
Authors: G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7,
Affiliations: 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Department of Public Health and Clinical Medicine - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden
Publications: 
European Journal of Heart Failure, 2016, Vol. 18, 48-48 p.
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Real World Evidence
 
 
Dosing of heart failure treatments in newly diagnosed unselected patients in Sweden: compliance with European society of cardiology guidelines
Authors: G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7
Affiliations: 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden
Publications: 
European Journal of Heart Failure
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Real World Evidence
 
 
Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence.
Authors: Rockberg J1, Amelio JM2, Taylor A2, Jörgensen L1, Ragnhammar P3, Hansson J4.
Affiliations: 1Pygargus AB/IMS Health Sweden AB, Pyramidvägen 7, Solna, Sweden 169 56. 2Amgen Inc, Uxbridge Business Park, Uxbridge, UK UB8 1DH. 3Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. 4Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. johan.hansson@ki.se.
Publications: 
Int J Cancer
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27563839
Condition Year Language Analysis type
, Oncology 2016 English , Epidemiological study, Real World Evidence
 
 
COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study
Authors: Hoti F, Mushnikov V, Mehtälä J, et al.
Affiliations: 
Publications: 
32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland
Document Types: , Abstract
Countries: , Germany, Nordic, Sweden, USA
Condition Year Language Analysis type
, Respiratory disease 2016 English , Real World Evidence
 
 
Dosing of heart failure treatments in newly diagnosed unselected patients in sweden: compliance with european society of cardiology guidelines
Authors: Wikström G, Boman K, Olofsson M, Lindmark K, Lahoz R, Corda S, Wintzell V, Linder R, Gondos A, Stalhammer J
Affiliations: Uppsala University, Institute for Medical Sciences, Uppsala, Sweden|IMS Health Sweden, Stockholm, Sweden
Publications: 
European Journal of Heart Failure. (2016) 18:341-341
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.539
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study
 
 
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden
Authors: Banefelt J, Hallberg S, Fox K M, Mesterton J, Paoli C J, Johansson G, Levin L-Å, Sobocki P, Gandra S R
Affiliations: Quantify Research Stockholm Sweden|IMS Health Stockholm Sweden
Publications: 
Eur J Health Econ (2016) 17: 1117
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://link.springer.com/article/10.1007/s10198-015-0749-y
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Cost of illness, Population Based Study, Retrospective cohort analysis
 
 
The Quality of Warfarin Therapy Among Atrial Fibrillation Patients in Finland ? Results from the FinWAF Registry
Authors: Mehtälä J, Raatikainen P, Lassila R, Khanfir H, Korhonen P, Hoti F, Lehto M
Affiliations: EPID Research, Espoo, Finland
Publications: 
Pharmacoepidemiology and Drug Safety (2016);25(Suppl. 3): pp. 3-680
Document Types: , Abstract
Countries: , Finland, Nordic
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4070
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Population Based Study, Retrospective database analysis
 
 
Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland
Authors: Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J
Affiliations: EPID Research, Espoo, Finland
Publications: 
BMJ Open (2016) 6:e012604
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://bmjopen.bmj.com/content/6/11/e012604.short
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Population Based Study, Retrospective database analysis
 
 
Age predicts initiation of and persistence with P2Y12 inhibitor treatment after acute coronary syndrome - results form a nationwide retrospective cohort in Finland
Authors: Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J
Affiliations: EPID Research, Espoo, Finland
Publications: 
European Heart Journal (2016 );37 ( Abstract Supplement ):939
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-5-Are-we-better-at-managing-cardiovascular-disease-in-the-el/139119-age-predicts-initiation-of-and-persistence-with-p2y12-inhibitor-treatment-after-acute-coronary-syndrome-results-from-a-nationwide-retrospective-cohort-in-finland
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Population Based Study, Retrospective database analysis
 
 
Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland.
Authors: Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J.
Affiliations: EPID Research, Espoo, Finland
Publications: 
European Heart Journal (2016);37(Abstract Supplement);378-379
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-2-Clinical-platelet-studies/140660-gender-differences-in-oral-antiplatelet-treatment-use-results-from-a-nationwide-cohort-study-of-acute-coronary-syndrome-patients-in-finland
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden
Authors: Henry N1, Hawes C1, Lowin J1, Lekander I2, Filonenko A3, Kallner HK4.
Affiliations: 1IMS Health, London, UK. 2Bayer AB, Solna, Sweden. 3Bayer Pharma AG, Berlin, Germany. 4Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
Publications: 
Acta Obstet Gynecol Scand. 2015 Aug;94(8):884-90
Document Types: , Article
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Womens Health 2015 English , Cost effectiveness
 
 
COST-EFFECTIVENESS OF DULAGLUTIDE 1.5MG ONCE WEEKLY FOR THE TREATMENT OF PATIENTS WITH TYPE TWO DIABETES MELLITUS IN SWEDEN
Authors: Raibouaa A1, Borgeke H2, Alexiou D3, Lowin J3, Norrbacka K4
Affiliations: 1Eli Lilly and Company Limited, Windlesham, Surrey, UK, 2Eli Lilly Sweden AB, Solna, Sweden, 3IMS Health, London, UK, 4Eli Lilly and Company, Helsinki, Finland
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
2015 English
 
 
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden.
Authors: Banefelt J1, Hallberg S2, Fox KM3, Mesterton J2,4, Paoli CJ5, Johansson G6, Levin LÅ7, Sobocki P4,8, Gandra SR5.
Affiliations: 1Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. jonas.banefelt@quantifyresearch.com. 2Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. 3Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 4LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 5Amgen Inc., Thousand Oaks, CA, USA. 6Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 7Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 8IMS Health, Stockholm, Sweden.
Publications: 
Eur J Health Econ
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://link.springer.com/article/10.1007%2Fs10198-015-0749-y
Condition Year Language Analysis type
, Cardiovascular disease 2015 English , Real World Evidence
 
 
Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Authors: Rockberg J1, Bach BA2, Amelio J3, Hernandez RK4, Sobocki P1, Engellau J5, Bauer HC6, Liede A7.
Affiliations: 1IMS Health (Pygargus), Sveavägen 155, SE-113 46, Stockholm, Sweden. 2Amgen Inc., One Amgen Center Drive, MS 38-2-B, Thousand Oaks, CA 91320-1799. 3Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, England. 4Amgen Inc., One Amgen Center Drive, MS 24-2-A, Thousand Oaks, CA 93120-1799. 5Lund University, SE-221 85 Lund, Sweden. 6Karolinska Universitetssjukhuset, Solna, A2:07,171 76 Stockholm, Sweden. 7Center for Observational Research, Amgen, Inc., 1120 Veterans Boulevard, ASF3, South San Francisco, CA 94080. E-mail address: aliede@amgen.com.
Publications: 
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://jbjs.org/content/97/21/1756.long
Condition Year Language Analysis type
, Oncology 2015 English , Real World Evidence
 
 
Estimating Rates of Cardiovascular Death Using Royston-Parmar Survival Models: An Example in a High Risk Patient Population in Sweden
Authors: Julia Sandberg1, Leif Jorgensen1, Mark Danese2, Benjamin Taylor3, Ryan Kilpatrick4 and Patrik Sobocki1
Affiliations: 1 IMS Health Sweden, 2 Outcomes Insights Inc. CA USA, 3 Amgen Inc. CA USA, 4 GSK NC USA
Publications: 
Circulation
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://circ.ahajournals.org/content/131/Suppl_1/AP233.abstract
Condition Year Language Analysis type
, Cardiovascular disease 2015 English , Real World Evidence
 
 
Characteristics, Referral and Treatment Patterns of Patients Diagnosed with Psoriatic Arthritis ? A Retrospective Cohort Study Based in Sweden
Authors: J. Rockberg1, M. Mittal2, A. Joshi2, Y. Bao2, J. Anderson3, R. Linder1, J. Stålhammar4, U. Lindqvist5
Affiliations: 1Real World Evidence Solutions & HEOR, Pygargus AB/IMS Health, Stockholm, Sweden 2Health Economics and Outcomes Research (HEOR) 3Immunology Clinical Development, AbbVie Inc, Chicago, United States 4Department of Public health and Caring Sciences; Family Medicine and Preventive Medicine 5Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Publications: 
Ann Rheum Dis
Document Types: , Oral presentation
Countries: , Nordic, Sweden
Abstract: http://ard.bmj.com/content/74/Suppl_2/64.2
Condition Year Language Analysis type
, Rheumatology 2015 English , Real World Evidence
 
 
Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting
Authors: Sabale U1, Bodegård J2, Sundström J3, Östgren CJ4, Nilsson P5, Johansson G3, Svennblad B3, Henriksson M2.
Affiliations: 1AstraZeneca Nordic-Baltic, Södertälje, Sweden. Electronic address: ugne.sabale@astrazeneca.com. 2AstraZeneca Nordic-Baltic, Södertälje, Sweden. 3Uppsala University, Uppsala, Sweden. 4Linköping University, Linköping, Sweden. 5Lund University, Malmö, Sweden
Publications: 
Prim Care Diabetes
Document Types: 
Countries: , Nordic, Sweden
Abstract: http://www.primary-care-diabetes.com/article/S1751-9918(15)00002-9/abstract
Condition Year Language Analysis type
, Diabetes 2015 English , Cost of illness, Real World Evidence
 
 
Weight change over time and its link to healthcare costs among newly-diagnosed type 2 diabetes patients in Sweden
Authors: U. Sabale1, J. Bodegard1, J. Sundström2, B. Svennblad2, C. Östgren3, P.M. Nilsson4, G. Johansson2, M.Ekman1
Affiliations: 1AstraZeneca, Södertälje, 2Uppsala University, Uppsala, 3Linköping University, Linköping, 4Lund University, Malmö, Sweden.
Publications: 
European Association for the Study of Diabetes (EASD) Annual Meeting; 2015; Stockholm.
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://staging.easdvirtualmeeting.org/resources/weight-change-over-time-and-its-link-to-healthcare-costs-among-newly-diagnosed-type-2-diabetes-patients-in-sweden--2
Condition Year Language Analysis type
, Diabetes 2015 English , Real World Evidence
 
 
Psychotropic drugs and homicide: a prospective cohort study from Finland
Authors: Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P
Affiliations: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Publications: 
World Psychiatry. (2015) 14(2):245-7
Document Types: , Letter
Countries: , Finland, Nordic
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/wps.20220
Condition Year Language Analysis type
, Mental health 2015 English , Population Based Study, Prospective study
 
 
Cost-effectiveness of dulaglutide 1.5mg once weekly for the treatment of patients with type two diabetes mellitus in Sweden
Authors: Raibouaa A1, Borgeke H2, Alexiou D3, Lowin J3, Norrbacka K4
Affiliations: 1Eli Lilly and Company Limited, Windlesham, Surrey, UK, 2Eli Lilly Sweden AB, Solna, Sweden, 3IMS Health, London, UK, 4Eli Lilly and Company, Helsinki, Finland
Publications: 
ISPOR, 18th Annual European Congress,7-11 November 2015
Document Types: , Abstract
Countries: , Italy, Nordic
Condition Year Language Analysis type
, Diabetes 2015 English , Cost effectiveness
 
 
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception
Authors: Henry N1, Schlueter M1, Lowin J1, Lekander I2, Filonenko A3, Trussell J4, Skjeldestad FE5
Affiliations: 1 Real World Evidence Solutions, IMS Health, London, UK. 2 Bayer AB, Solna, Sweden. 3 Bayer Pharma AG, Berlin, Germany. 4 Office of Population Research, Princeton University, Princeton, NJ, USA. 5 Department of Clinical Medicine, University of Tromsø, Tromsø, Norway
Publications: 
Document Types: , Article
Countries: , Nordic, UK
Condition Year Language Analysis type
, Pregnancy 2015 English , Retrospective database analysis
 
 
Population-based study of giant cell tumour of the bone in Sweden
Authors: Amelio J1, Sandberg J2, Hernandez RK4, Sobocki P2,Stryker S4, Engellau J3, Bach BA4, Liede A4
Affiliations: 1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of oncology, Lund University Hospital, 221 00 - Lund/SE
Publications: 
ESMO 2014
CTOS 19th Annual Meeting, October 15- 18, 2014 at the InterContinental Hotel in Berlin, Germany
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden
Condition Year Language Analysis type
, Oncology 2014 English , Database Study
 
 
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia - estimates from population-based register data in Sweden
Authors: Banefelt J1, Hallberg S1, Fox KM2, Mesterton J1, Paoli CJ3, Johansson G4, Levin L5, Sobocki P6, Gandra SR3
Affiliations: 1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Amgen, Inc., Thousand Oaks, CA, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden
Publications: 
ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
Document Types: , Podium presentation
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Cost of illness
 
 
Burden of hyperlipidemia resulting from productivity loss - estimates from population-based register data in Sweden
Authors: Banefelt J1, Hallberg S1, Gandra SR2, Mesterton J1, Fox KM3, Paoli CJ2, Johansson G4, Levin L5, Sobocki P6
Affiliations: Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden
Publications: 
ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Burden of illness
 
 
Transforming oncology outcomes research through data linkage in Sweden: A unique real-world lens on the entire patient journey
Authors: Sobocki P
Affiliations: IMS Health, Stockholm, Sweden
Publications: 
AccessPoint, 2014, May; 4(8): 21-25
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition Year Language Analysis type
, Methodology, Oncology 2014 English , Real World Evidence
 
 
HEALTH CARE COSTS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERLIPIDEMIA - ESTIMATES FROM POPULATION-BASED REGISTER DATA IN SWEDEN
Authors: Hallberg S1, Banefelt J1, Mesterton J1, Gandra SR2, Fox KM3, Johansson G4, Levin L5, Sobocki P6
Affiliations: 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden
Publications: 
ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://www.ispor.org/research_study_digest/details.asp
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Real World Evidence
 
 
LDL-C goal attainment in patients with hyperlipidemia - estimates from population-based register data in Sweden
Authors: Mesterton J1, Hallberg S1, Gandra SR2, Banefelt J1, Fox KM3, Johansson G4, Levin L5, Sobocki P6
Affiliations: Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Population Based Study
 
 
Treatment patterns in hyperlipidemia patients with new cardiovascular events - estimates from population-based register data in Sweden
Authors: Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1, Johansson G3, Levin L4, Sobocki P5, Gandra SR6
Affiliations: 1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Uppsala University, Uppsala, Sweden, 4Linköping University, Linköping, Sweden, 5IMS Health, Stockholm, Sweden, 6Amgen, Inc., Thousand Oaks, CA, USA
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Database Study
 
 
Retrospective database study on healthcare resource utilization of patients initiating long-acting olanzapine in Sweden
Authors: Tockhorn A1, Johansson S2, Borgeke H3
Affiliations: 1Eli Lilly UK, Windlesham, Surrey, UK, 2IMS Health Sweden, 113 46 Stockholm, Sweden, 3Eli Lilly and Company, Stockholm, Sweden
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Mental health 2014 English , Retrospective database analysis
 
 
Cost-effectiveness of ipilimumab in previously untreated patients for advanced melanoma in Sweden
Authors: Barzey V1, Asukai Y1, Gueron B2, Holmberg C3, Kotapati S4
Affiliations: 1IMS Health, London, UK, 2Bristol-Myers Squibb, Rueil Malmasion, France, 3Bristol-Myers Squibb, Bromma, Sweden, 4Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Oncology 2014 English , Cost effectiveness
 
 
Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden
Authors: Banefelt J1, Liede A2, Mesterton J3, Stålhammar J4, Hernandez RK5, Sobocki P6, Persson BE7.
Affiliations: 1Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden. 2Amgen Inc., Center for Observational Research, South San Francisco, CA, United States. 3Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institute, 171 77 Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, 751 22 Uppsala, Sweden. 5Amgen Inc., Center for Observational Research, One Amgen Center Drive 24-2-A, Thousand Oaks, CA 91320, United States. 6IMS Health/Pygargus, Sveavägen 155, 113 46 Stockholm, Sweden; LIME/Medical Management Centre, Karolinska Institute, 171 77 Stockholm, Sweden. 7Uppsala University, 751 05 Uppsala, Sweden. Electronic address: Bo-Eric.Persson@ferring.com.
Publications: 
Cancer Epidemiol
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(14)00089-7/abstract
Condition Year Language Analysis type
, Oncology 2014 English , Real World Evidence
 
 
Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden
Authors: Banefelt J.1, Hallberg S.1, Gandra S.R.2, Mesterton J.1, Fox K.M.3, Paoli C.J.2, Johansson G.4, Levin L.Å.5, Sobocki P.6
Affiliations: 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden
Publications: 
Value in Health
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03384-1/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Real World Evidence
 
 
Trends in giant cell tumour of the bone and osteosarcoma incidence in the Sweden (1958-2011.
Authors: A. Liede1, J. Sandberg2, J. Amelio3, R.K. Hernandez4, P. Sobocki2, H.C..F. Bauer5, B. Bach6, J. Engellau7
Affiliations: 1Center For Observational Research, Amgen Inc., 94080 - South San Francisco/US 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 4Center For Observational Research, Amgen Inc., 91320 - Thousand Oaks/US 5Molecular Medicine And Surgery, Karolinska Institute, Stockholm/SE 6Clinical Development, Amgen Inc., Thousand Oaks/US 7Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE
Publications: 
European Society for Medical Oncology (ESMO) Meeting 2014, Madrid Spain, 29 September
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Trends-in-Giant-Cell-Tumour-of-the-Bone-and-Osteosarcoma-Incidence-in-the-Sweden-1958-2011
Condition Year Language Analysis type
, Oncology 2014 English , Real World Evidence
 
 
Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)
Authors: Ställberg B1, Janson C, Johansson G, Larsson K, Stratelis G, Telg G, Lisspers KH.
Affiliations: 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden
Publications: 
Prim Care Respir J
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.nature.com/articles/pcrj2013106
Condition Year Language Analysis type
, Respiratory disease 2014 English , Epidemiological study, Real World Evidence
 
 
Patients with COPD who Initiate Roflumilast in Sweden
Authors: Khalid J.M.1, Mushnikov V.2, Vattulainen P.2, Johansson G.3, Korhonen P. 2, Hoti F.2
Affiliations: 1Takeda Development Centre Europe, Ltd., London, UK, 2EPID Research, Espoo, Finland, 3Uppsala University, Uppsala, Sweden
Publications: 
ISPOR 17th Annual European Congress, nov 8-12, 2014, Amsterdam, The Netherlands.
Document Types: 
Countries: , Nordic, Sweden
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03952-7/abstract
Condition Year Language Analysis type
, Respiratory disease 2014 English , Real World Evidence
 
 
Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden
Authors: U. Sabale1, J. Bodegård1, J. Sundström2, B. Svennblad3, C.J. Östgren4, P. Nilsson5, G. Johansson3, M. Henriksson1
Affiliations: 1 AstraZeneca Nordic-Baltic, Södertälje, Sweden, 2 Uppsala University, Uppsala, Australia, 3 Uppsala University, Uppsala, Sweden, 4 Linköping University, Linköping, Sweden, 5 Lund University, Malmö, Sweden
Publications: 
Value in Health
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://www.sciencedirect.com/science/article/pii/S109830151402590X
Condition Year Language Analysis type
, Diabetes 2014 English , Real World Evidence
 
 
Population-based study of Giant Cell Tumor of the bone in Sweden
Authors: Amelio J, Sandberg J, Hernandez R, Sobocki P, Stryker S, Engellau J, Bach B, Liede A
Affiliations: Center for Oberservational Research, Amgen Ltd., Uxbridge, UK|IMS Health, Stockholm Sweden
Publications: 
Annals of Oncology (2014) 25(suppl 4):iv509-iv510
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv509/2242151
Condition Year Language Analysis type
, Oncology 2014 English , Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden
Authors: Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LA, Sobocki P, Gandra SR
Affiliations: Quantify Research, Stockholm, Sweden|IMS Health, Stockholm, Sweden
Publications: 
Value in health:The journal of the International Society for Pharmacoeconomics and Outcomes Research (2014);17(7):A327-328
Document Types: , Oral presentation
Countries: , Nordic, Sweden
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02526-1/fulltext
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Cost analysis, Cost of illness, Population Based Study, Retrospective database analysis
 
 
Exacerbations and healthcare resource utilization among COPD patients in Sweden
Authors: Hoti F, Mushnikov V, Vattulainen P, Johansson G, Khalid JM, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: 
ERS International Congress 2014, Munich, Germany, 6-10 Sep, 2014
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://epidresearch.com/wp-content/uploads/2016/11/EPID-Research-poster-ERS-2014.pdf
Condition Year Language Analysis type
, Respiratory disease 2014 English , Burden of illness, Clinical setting: hospital, clinical setting: Secondary care, Population Based Study, Retrospective database analysis
 
 
Patients With COPD who Initiate Roflumilast in Sweden
Authors: Khalid JM, Mushnikov V, Vattulainen P, Johansson G, Korhonen P, Hoti F
Affiliations: Takeda Development Centre Europe, Ltd., London, UK.
Publications: 
Value Health (2014);17(7): A590
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: https://ac.els-cdn.com/S1098301514039527/1-s2.0-S1098301514039527-main.pdf?_tid=8ac08c65-061d-4f1f-9dd7-ab7e57390da9&acdnat=1537855638_d812a58ce69b69727a8d22b21f1ed84a
Condition Year Language Analysis type
, Respiratory disease 2014 English , Observational study, Population Based Study
 
 
ASSOCIATION OF CHANGES IN BODY WEIGHT WITH HEALTH CARE COSTS AMONG PATIENTS WITH NEWLY-DIAGNOSED TYPE-2 DIABETES IN SWEDEN
Authors: Sabale U, Bodegård J, Sundström J, Svennblad B, Östgren CJ, Nilsson P, Johansson G, Henriksson M
Affiliations: AstraZeneca Nordic-Baltic, Södertälje, Sweden
Publications: 
Value in Health (2014);17(7): A338
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02590-X/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Cost analysis, Population Based Study, Retrospective database analysis
 
 
Regional assessment of severe hypoglycemic coma events in Finland
Authors: Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P.
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value Health. (2014) 17(7): A332
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study, Observational study, Population Based Study
 
 
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland
Authors: Mäkimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
Diabetes (2014);63 (Suppl 1):A343-A425
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: http://diabetes.diabetesjournals.org/mwg-internal/de5fs23hu73ds/progress?id=tLDZcQ3XmqwM1R5WmUnmnK6ZYf5Vk0j-7PYr0VdNiOQ,&dl
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Uses of Electronic Patient Information Systems and National Registers ? Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland
Authors: Prami T, Sulamaa A, Sipilä R, Linna M, Hahl J, Miettinen T, Leppä E, Haukka J, Tuomilehto J, Enlund H, Niskanen L, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value in Health. (2014);17(7): A336
Document Types: , Abstract
Countries: , Finland, Nordic
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02579-0/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Population Based Study
 
 
Regional Assessment of Severe Hypoglycemic Coma Events in Finland
Authors: Hoti F, Vattulainen P, Mushnikov V, Saukkonen T, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value in Health (2014);17(7):A332
Document Types: , Poster
Countries: , Finland, Nordic
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study, Observational study, Population Based Study
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Norway
Authors: Troelsgaard A1, Huetson P2, Kjellberg J3, Hemels M1, Knudsen M4
Affiliations: Janssen A/S, Birkerød, Denmark, 2IMS Health, Stockholm, Sweden, 3Zefferin Farma AB, Stockholm, Sweden, 4IMS Health, Hellerup, Denmark
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Norway
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden
Authors: Fredrikson S1, McLeod E2, Henry N2, Pitcher A2, Lowin J2, Cuche M3, Fajutrao L4, Perard R5, Bates D6, Chan A7
Affiliations: 1 Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden 2 IMS Health, London, UK 3 Merck Serono S.A., Geneva, Switzerland 4 Merck AB, Solna, Sweden 5 Merck Serono Ltd, Middlesex, UK 6 Newcastle University, Newcastle upon Tyne, UK 7 Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany
Publications: 
J Med Econ. 2013;16(6):756-62.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696998.2013.792824?journalCode=jme
Condition Year Language Analysis type
, Neurological disorders 2013 English , Cost effectiveness
 
 
Length of stay and costs for patients with recurrent Clostridium Difficile infections in Sweden
Authors: Norén T1, Bruce S2, Fagerlund K3, Nordling S3
Affiliations: 1Department of Infectious Diseases, Örebro, Sweden, 2IMS Health, Stockholm, Sweden, 3Astellas Pharma Nordic, Kastrup, Denmark
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx
Condition Year Language Analysis type
, Infectious disease 2012 English , Cost analysis
 
 
COPD in primary care in Sweden - An 11 years epidemiological register study
Authors: Karin Lisspers1, Kjell Larsson2, Björn Ställberg1, Christer Janson3, Gunilla Telg4, Leif Jörgensen4, Georgios Stratelis4 and Gunnar Johansson1
Affiliations: 1Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 2Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden 3Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 4Medical, AstraZeneca Nordic, Södertälje, Sweden
Publications: 
Eur Respir J
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://erj.ersjournals.com/content/40/Suppl_56/4339.article-info
Condition Year Language Analysis type
, Respiratory disease 2012 English , Real World Evidence
 
 
Drug utilisation adaptions in Sweden after the Effexor patent expiry
Authors: Bruce S, Hjelmgren J, Löfroth E, Myrén KJ.
Affiliations: IMS Consulting Group, Stockholm, Sweden.
Publications: 
ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
, Clinical practice, Health policy, Mental health 2011 English , Retrospective database analysis
 
 
Healthcare encounters among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden
Authors: Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5
Affiliations: 1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3 Novartis Pharmaceuticals Corporation, East Hanover, USA, 4IMS Health (Formally Pygargus AB), Stockholm, Sweden, 5Analytica International, New York, USA
Publications: 
European Heart Failure Congress, Gothenbourg, May 21-24, 2011
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7804&subSessId=1013&searchQuery=&presId=54107&doc=Abstract
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Cost utility, Retrospective database analysis
 
 
Mortality and admission rates among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden
Authors: Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5
Affiliations: 1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3Novartis Pharmaceuticals Corporation,East Hanover,USA, 4IMS Health,(Formally Pygargus AB)Stockholm, Sweden, 5Analytica International, New York, USA
Publications: 
European Heart Failure Congress, Gothenbourg, May 21-24, 2011
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://spo.escardio.org/Abstract.aspx?eevtid=46&fp=P1289
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Mortality and admission rates among heart failure (HF) patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden
Authors: Wikstrom G, Stalhammar J, Ariely R, Linder R, Ogbonnaya A, Stern L
Affiliations: Uppsala University, Department of Medical Sciences, Cardiology - Uppsala - Sweden
Publications: 
European Journal of Heart Failure Supplements (2011) 10 ( S1 ), S251
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: https://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7810&subSessId=1138&searchQuery=%2fdefault.aspx%3feevtid%3d46%26days%3d%26topics%3d%26types%3d%26rooms%3d%26freetext%3dAriely%26sort%3d1%26page%3d1%26showResults%3dTrue%26nbPerPage%3d20%26WithWebcast%3d%26WithSlides%3d%26WithAbstract%3d%26WithReport%3d
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Retrospective database analysis
 
 
Healthcare encounters among heart failure (HF) patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden
Authors: Wikstrom G, Stalhammar J, Ariely R, Linder R, Ogbonnaya A, Stern L
Affiliations: Uppsala University, Department of Medical Sciences, Cardiology - Uppsala - Sweden
Publications: 
European Journal of Heart Failure Supplements (2011) 10 ( S1 ), S92
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: https://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7804&subSessId=1013&searchQuery=%2fdefault.aspx%3feevtid%3d46%26days%3d%26topics%3d%26types%3d%26rooms%3d%26freetext%3dAriely%26sort%3d1%26page%3d1%26showResults%3dTrue%26nbPerPage%3d20%26WithWebcast%3d%26WithSlides%3d%26WithAbstract%3d%26WithReport%3d
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Retrospective database analysis
 
 
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
Authors: Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5
Affiliations: 1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland
Publications: 
Scandinavian journal of public health
Document Types: , Manuscript in preparation
Countries: , Nordic, Switzerland
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20688795
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Prevalence of affective disorders in South-West region of Sweden.
Authors: Löfroth E, Myrén KJ, Bruce S, Dahlberg E.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Atomoxetine's effect on societal costs in Sweden
Authors: Myrén KJ, Thernlund G, Nylén A, Schacht A, Svanborg P
Affiliations: IMS Health Sweden AB.
Publications: 
J Atten Disord. 2010 May;13(6):618-28. Epub 2009 Apr 13
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=%22journal+of+attention+disorders%22%5BJour%5D+AND+13%5Bvolume%5D+AND+618%5Bpage%5D+AND+2010%5Bpdat%5D&cmd=detailssearch
Condition Year Language Analysis type
, Neurological disorders 2010 English , Burden of illness
 
 
Cost-effectiveness of tapentadol prolonged-release (PR) compared to oxycodone and morphine in patients with chronic moderate to severe non-cancer pain in Sweden
Authors: Hertel N1, Ikenberg R1, Fricke FU12, Liedgens H3
Affiliations: 1IMS Health, Nuremberg, Germany 2Georg Simon Ohm University of Applied Sciences, Nuremberg, Germany 3Gruenenthal GmbH, Aachen, Germany
Publications: 
ISPOR November 6-9, 2010 Prague, Czech Republic
Document Types: , Abstract
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Health economics, Musculoskeletal disease 2010 English , Cost benefit
 
 
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.
Authors: Moeremans K1, Hemmett L2, Hjelmgren J3, Allegri G4, Smets E5
Affiliations: 1 IMS Health, Brussels, Belgium 2 Tibotec, Buckinghamshire, UK 3 Janssen-Cilag AB, Stockholm, Sweden 4 Janssen-Cilag SpA, Cologno Monzese, Italy 5 Johnson & Johnson Pharmaceutical Services LLC, Mechelen, Belgium
Publications: 
Pharmacoeconomics, 2010, 28 (Suppl 1): 147-167
Document Types: , Article
Countries: , Belgium, Italy, Nordic, Sweden, UK
Condition Year Language Analysis type
, HIV AIDS 2010 English , Cost effectiveness
 
 
Daily costs of Prostaglandin analogues as monotherapy or in fixed combinations with Timolol, in Denmark, Finland, Germany and Sweden
Authors: Bergstrom A1, Maurel F2, Le Pen C3, Lamure E2, Kent M4, Bardoulat I2,Berdeaux GH5,6
Affiliations: 1 Lund Hospital, Lund, Sweden 2 IMS France, Puteaux, France 3 Université Paris-Dauphine, Paris, France 4 Alcon Inc, Fort Worth, Texas, USA 5 Alcon France SA, Rueil-Malmaison, France 6Conservatoire National des Arts et Métiers, Paris, France
Publications: 
Clin Ophthalmol. 2009;3:471-81
Document Types: , Article
Countries: , Denmark, Finland, Germany, Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732058/?tool=pubmed
Condition Year Language Analysis type
, Ophthalmology 2009 English , Economic evaluation
 
 
Cost-effectiveness of etravirine in Sweden in treatment-experienced HIV-1-infected adults with evidence of NNRTI resistance and ? 3 PI mutations.
Authors: Moeremans K1, Hjelmgren J2, Martin S3
Affiliations: 1 IMS Health, Brussels, Belgium 2 Janssen-Cilag, Birkeöd, Denmark 3 J&J, Mechelen, Belgium
Publications: 
12th European Aids Conference, 2009, November 11-14, Cologne, Germany
ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, HIV AIDS 2009 English , Cost utility
 
 
The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
Authors: Ringborg A, Yin DD, Martinell M, Stålhammar J, Lindgren P.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):576-82. doi: 10.1097/HJR.0b013e32832d193b.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=The+impact+of+acute+myocardial+infarction+and+stroke+on+health+care+costs+in+patients+with+type+2+diabetes+in+Sweden&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2009 English , Burden of illness, Cost of illness
 
 
Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort
Authors: Haukka J, Arffman M, Partonen T, Sihvo S, Elovainio M, Tiihonen J, Lönnqvist J, Keskimäki I
Affiliations: National Institute for Health and Welfare, Helsinki, Finland
Publications: 
European Journal of Clinical Pharmacology (2009); 65(7):715-20
Document Types: , Article
Countries: , Finland, Nordic
Condition Year Language Analysis type
, Mental health 2009 English , Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Long-term cost-effectiveness of insulin detemir compared to neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal?bolus regimen in Sweden.
Authors: Valentine WJ1, Lammert M2, Aagren M3, Gschwend M1.
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk Scandinavia AB, Copenhagen, Denmark; 3 Novo Nordisk, Bagsværd, Denmark
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
Authors: Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Int J Clin Pract. 2008 May;62(5):708-16. doi: 10.1111/j.1742-1241.2008.01716.x. Epub 2008 Mar 17.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Resource+use+and+costs+of+type+2+diabetes+in+Sweden+%E2%80%93+estimates+from+population-based+register+data&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2008 English , Cost consequence, Cost of illness
 
 
Evaluating the clinical effects and the cost-effectiveness of prophylactic cervical cancer vaccination within an organised population-based screening setting ? case Finland
Authors: Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: , Finland, Nordic
Condition Year Language Analysis type
, Oncology 2007 English , Cost effectiveness
 
 
Adaptation of a health economic model of the natural history of HPV infection and cervical cancer in a well functioning population-based screening system ? a model calibration to Finland
Authors: Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: , Finland, Nordic
Condition Year Language Analysis type
, Oncology 2007 English
 
 
Long-term clinical and economic outcomes for patients with type 1 diabetes treated with insulin aspart versus human soluble insulin in Sweden
Authors: Tucker D1, Brandt AS2, Foos V1, Munro V3, Goodall G1, Ray J1,Valentine WJ1, Roze S1, Palmer AJ1
Affiliations: 1 1 CORE?Center for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Novo Nordisk Scandinavia AB, Malmo, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK
Publications: 

Value in Health, Vol. 9, Issue 6, A226–A227
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Diabetes 2006 English , Economic evaluation
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.